Activation of the cytotoxic programs in NK cells and CD8+ T cells is key for cancer immunotherapy, and consequently early studies provided compelling evidence that IL-21 is a promising immunotherapeutic agent for this disease56. The gene discussed is IL21; the disease is cancer.